메뉴 건너뛰기




Volumn 128, Issue 24, 2016, Pages 2824-2833

Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature

(23)  Kavanagh, David a   McGlasson, Sarah b   Jury, Alexa b   Williams, Jac c   Scolding, Neil d   Bellamy, Chris e   Gunther, Claudia f   Ritchie, Diane c   Gale, Daniel P g   Kanwar, Yashpal S h   Challis, Rachel a   Buist, Holly i   Overell, James j   Weller, Belinda c   Flossmann, Oliver k   Blunden, Mark l   Meyer, Eric P m   Krucker, Thomas n   Evans, Stephen J W o   Campbell, Iain L p   more..


Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON RECEPTOR; BETA INTERFERON; BETA INTERFERON RECEPTOR; INTERFERON; RECOMBINANT INTERFERON;

EID: 84999881304     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2016-05-715987     Document Type: Article
Times cited : (92)

References (43)
  • 1
    • 84921646968 scopus 로고    scopus 로고
    • Drug-induced thrombotic microangiopathy: A systematic review of published reports
    • Al-Nouri ZL, Reese JA, Terrell DR, Vesely SK, George JN. Drug-induced thrombotic microangiopathy: a systematic review of published reports. Blood. 2015;125(4):616-618.
    • (2015) Blood , vol.125 , Issue.4 , pp. 616-618
    • Al-Nouri, Z.L.1    Reese, J.A.2    Terrell, D.R.3    Vesely, S.K.4    George, J.N.5
  • 2
    • 84908590395 scopus 로고    scopus 로고
    • Syndromes of thrombotic microangiopathy
    • George JN, Nester CM. Syndromes of thrombotic microangiopathy. N Engl J Med. 2014;371(19):1847-1848.
    • (2014) N Engl J Med. , vol.371 , Issue.19 , pp. 1847-1848
    • George, J.N.1    Nester, C.M.2
  • 4
    • 84941022179 scopus 로고    scopus 로고
    • Type I interferon dysregulation and neurological disease
    • McGlasson S, Jury A, Jackson A, Hunt D. Type I interferon dysregulation and neurological disease. Nat Rev Neurol. 2015;11(9):515-523.
    • (2015) Nat Rev Neurol. , vol.11 , Issue.9 , pp. 515-523
    • McGlasson, S.1    Jury, A.2    Jackson, A.3    Hunt, D.4
  • 5
    • 0036311308 scopus 로고    scopus 로고
    • Alpha-interferon-associated thrombotic microangiopathy: A clinicopathologic study of 8 patients and review of the literature
    • Zuber J, Martinez F, Droz D, Oksenhendler E, Legendre C; Groupe D'stude Des Nephrologues D'ile-de-France (GENIF). Alpha-interferon-associated thrombotic microangiopathy: a clinicopathologic study of 8 patients and review of the literature. Medicine (Baltimore). 2002;81(4):321-331.
    • (2002) Medicine (Baltimore) , vol.81 , Issue.4 , pp. 321-331
    • Zuber, J.1    Martinez, F.2    Droz, D.3    Oksenhendler, E.4    Legendre, C.5
  • 6
    • 84896996710 scopus 로고    scopus 로고
    • Thrombotic microangiopathy associated with interferon beta
    • Hunt D, Kavanagh D, Drummond I, et al. Thrombotic microangiopathy associated with interferon beta. N Engl J Med. 2014;370(13):1270-1271.
    • (2014) N Engl J Med. , vol.370 , Issue.13 , pp. 1270-1271
    • Hunt, D.1    Kavanagh, D.2    Drummond, I.3
  • 7
    • 84911421679 scopus 로고    scopus 로고
    • Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in relapsing-remitting multiple sclerosis patients on high-dose interferon β
    • Larochelle C, Grand'maison F, Bernier GP, Latour M, Cailhier JF, Prat A. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in relapsing-remitting multiple sclerosis patients on high-dose interferon β. Mult Scler. 2014;20(13):1783-1787.
    • (2014) Mult Scler , vol.20 , Issue.13 , pp. 1783-1787
    • Larochelle, C.1    Grand'maison, F.2    Bernier, G.P.3    Latour, M.4    Cailhier, J.F.5    Prat, A.6
  • 8
    • 84930088944 scopus 로고    scopus 로고
    • Cumulative review of thrombotic microangiopathy, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome reports with subcutaneous interferon β-1a
    • Ben-Amor AF, Trochanov A, Fischer TZ. Cumulative review of thrombotic microangiopathy, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome reports with subcutaneous interferon β-1a. Adv Ther. 2015;32(5):445-454.
    • (2015) Adv Ther. , vol.32 , Issue.5 , pp. 445-454
    • Ben-Amor, A.F.1    Trochanov, A.2    Fischer, T.Z.3
  • 9
    • 0036307464 scopus 로고    scopus 로고
    • Causal association in pharmacovigilance and pharmacoepidemiology: Thoughts on the application of the Austin Bradford-Hill criteria
    • Shakir SA, Layton D. Causal association in pharmacovigilance and pharmacoepidemiology: thoughts on the application of the Austin Bradford-Hill criteria. Drug Saf. 2002;25(6):467-471.
    • (2002) Drug Saf , vol.25 , Issue.6 , pp. 467-471
    • Shakir, S.A.1    Layton, D.2
  • 10
    • 31844443695 scopus 로고
    • The environment and disease: Association or causation?
    • Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58(5):295-300.
    • (1965) Proc R Soc Med. , vol.58 , Issue.5 , pp. 295-300
    • Hill, A.B.1
  • 11
    • 10444255401 scopus 로고    scopus 로고
    • Intravenous immunoglobulin and the kidney - A two-edged sword
    • Orbach H, Tishler M, Shoenfeld Y. Intravenous immunoglobulin and the kidney - a two-edged sword. Semin Arthritis Rheum. 2004;34(3):593-601.
    • (2004) Semin Arthritis Rheum. , vol.34 , Issue.3 , pp. 593-601
    • Orbach, H.1    Tishler, M.2    Shoenfeld, Y.3
  • 12
    • 0037075272 scopus 로고    scopus 로고
    • Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin
    • Casadevall N, Nataf J, Viron B, et al. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med. 2002;346(7):469-475.
    • (2002) N Engl J Med. , vol.346 , Issue.7 , pp. 469-475
    • Casadevall, N.1    Nataf, J.2    Viron, B.3
  • 13
    • 84964480157 scopus 로고    scopus 로고
    • A national specialized service in England for atypical haemolytic uraemic syndrome - The first year's experience
    • Sheerin NS, Kavanagh D, Goodship TH, Johnson S. A national specialized service in England for atypical haemolytic uraemic syndrome - the first year's experience. QJM. 2016;109(1):27-33.
    • (2016) QJM , vol.109 , Issue.1 , pp. 27-33
    • Sheerin, N.S.1    Kavanagh, D.2    Goodship, T.H.3    Johnson, S.4
  • 14
    • 84876575052 scopus 로고    scopus 로고
    • INTERFEROME v2.0: An updated database of annotated interferon-regulated genes
    • Rusinova I, Forster S, Yu S, et al. INTERFEROME v2.0: an updated database of annotated interferon-regulated genes. Nucleic Acids Res. 2013;41(D1):D1040-D1046.
    • (2013) Nucleic Acids Res. , vol.41 , Issue.D1 , pp. D1040-D1046
    • Rusinova, I.1    Forster, S.2    Yu, S.3
  • 15
    • 33846255059 scopus 로고    scopus 로고
    • Identification of genes selectively regulated by IFNs in endothelial cells
    • Indraccolo S, Pfeffer U, Minuzzo S, et al. Identification of genes selectively regulated by IFNs in endothelial cells. J Immunol. 2007;178(2):1122-1135.
    • (2007) J Immunol. , vol.178 , Issue.2 , pp. 1122-1135
    • Indraccolo, S.1    Pfeffer, U.2    Minuzzo, S.3
  • 16
    • 0032211097 scopus 로고    scopus 로고
    • Transgenic expression of IFN-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration
    • Akwa Y, Hassett DE, Eloranta ML, et al. Transgenic expression of IFN-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration. J Immunol. 1998;161(9):5016-5026.
    • (1998) J Immunol. , vol.161 , Issue.9 , pp. 5016-5026
    • Akwa, Y.1    Hassett, D.E.2    Eloranta, M.L.3
  • 17
    • 0028070714 scopus 로고
    • Functional role of type I and type II interferons in antiviral defense
    • Müller U, Steinhoff U, Reis LF, et al. Functional role of type I and type II interferons in antiviral defense. Science. 1994;264(5167):1918-1921.
    • (1994) Science , vol.264 , Issue.5167 , pp. 1918-1921
    • Müller, U.1    Steinhoff, U.2    Reis, L.F.3
  • 18
    • 84893676729 scopus 로고    scopus 로고
    • Transsignaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain
    • Campbell IL, Erta M, Lim SL, et al. Transsignaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain. J Neurosci. 2014;34(7):2503-2513.
    • (2014) J Neurosci , vol.34 , Issue.7 , pp. 2503-2513
    • Campbell, I.L.1    Erta, M.2    Lim, S.L.3
  • 19
    • 75749098510 scopus 로고    scopus 로고
    • The type I interferon-alpha mediates a more severe neurological disease in the absence of the canonical signaling molecule interferon regulatory factor 9
    • Hofer MJ, Li W, Lim SL, Campbell IL. The type I interferon-alpha mediates a more severe neurological disease in the absence of the canonical signaling molecule interferon regulatory factor 9. J Neurosci. 2010;30(3):1149-1157.
    • (2010) J Neurosci , vol.30 , Issue.3 , pp. 1149-1157
    • Hofer, M.J.1    Li, W.2    Lim, S.L.3    Campbell, I.L.4
  • 20
    • 42149161677 scopus 로고    scopus 로고
    • Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer's disease
    • Meyer EP, Ulmann-Schuler A, Staufenbiel M, Krucker T. Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer's disease. Proc Natl Acad Sci USA. 2008;105(9):3587-3592.
    • (2008) Proc Natl Acad Sci USA , vol.105 , Issue.9 , pp. 3587-3592
    • Meyer, E.P.1    Ulmann-Schuler, A.2    Staufenbiel, M.3    Krucker, T.4
  • 21
    • 33747159590 scopus 로고    scopus 로고
    • Genetics of HUS: The impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome
    • International Registry of Recurrent and Familial HUS/TTP
    • Caprioli J, Noris M, Brioschi S, et al; International Registry of Recurrent and Familial HUS/TTP. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood. 2006;108(4):1267-1279.
    • (2006) Blood , vol.108 , Issue.4 , pp. 1267-1279
    • Caprioli, J.1    Noris, M.2    Brioschi, S.3
  • 22
    • 84902589905 scopus 로고    scopus 로고
    • Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP
    • Cataland SR, Holers VM, Geyer S, Yang S, Wu HM. Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP. Blood. 2014;123(24):3733-3738.
    • (2014) Blood , vol.123 , Issue.24 , pp. 3733-3738
    • Cataland, S.R.1    Holers, V.M.2    Geyer, S.3    Yang, S.4    Wu, H.M.5
  • 23
    • 84927526565 scopus 로고    scopus 로고
    • Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome
    • Schramm EC, Roumenina LT, Rybkine T, et al. Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome. Blood. 2015;125(15):2359-2369.
    • (2015) Blood , vol.125 , Issue.15 , pp. 2359-2369
    • Schramm, E.C.1    Roumenina, L.T.2    Rybkine, T.3
  • 24
    • 40849130173 scopus 로고    scopus 로고
    • VEGF inhibition and renal thrombotic microangiopathy
    • Eremina V, Jefferson JA, Kowalewska J, et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med. 2008;358(11):1129-1136.
    • (2008) N Engl J Med. , vol.358 , Issue.11 , pp. 1129-1136
    • Eremina, V.1    Jefferson, J.A.2    Kowalewska, J.3
  • 25
    • 38349172121 scopus 로고    scopus 로고
    • Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome
    • Fang CJ, Fremeaux-Bacchi V, Liszewski MK, et al. Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome. Blood. 2008;111(2):624-632.
    • (2008) Blood , vol.111 , Issue.2 , pp. 624-632
    • Fang, C.J.1    Fremeaux-Bacchi, V.2    Liszewski, M.K.3
  • 26
    • 78650106911 scopus 로고    scopus 로고
    • Anthropometric Reference Data for Children and Adults: United States, 2003-2006
    • Hyattsville, MD: National Center for Health Statistics
    • McDowell MA, Fryar CD, Ogden CL, Flegal KM. Anthropometric Reference Data for Children and Adults: United States, 2003-2006. Hyattsville, MD: National Center for Health Statistics, 2008. National Health Statistics Reports, no. 10.
    • (2008) National Health Statistics Reports
    • McDowell, M.A.1    Fryar, C.D.2    Ogden, C.L.3    Flegal, K.M.4
  • 27
    • 84933279572 scopus 로고    scopus 로고
    • Aicardi-Goutières syndrome and the type I interferonopathies
    • Crow YJ, Manel N. Aicardi-Goutières syndrome and the type I interferonopathies. Nat Rev Immunol. 2015;15(7):429-440.
    • (2015) Nat Rev Immunol. , vol.15 , Issue.7 , pp. 429-440
    • Crow, Y.J.1    Manel, N.2
  • 28
    • 84887607415 scopus 로고    scopus 로고
    • Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: A case-control study
    • Rice GI, Forte GM, Szynkiewicz M, et al. Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study. Lancet Neurol. 2013;12(12):1159-1169.
    • (2013) Lancet Neurol. , vol.12 , Issue.12 , pp. 1159-1169
    • Rice, G.I.1    Forte, G.M.2    Szynkiewicz, M.3
  • 29
    • 0344492212 scopus 로고    scopus 로고
    • Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus
    • Baechler EC, Batliwalla FM, Karypis G, et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA. 2003;100(5):2610-2615.
    • (2003) Proc Natl Acad Sci USA , vol.100 , Issue.5 , pp. 2610-2615
    • Baechler, E.C.1    Batliwalla, F.M.2    Karypis, G.3
  • 30
    • 2442517486 scopus 로고    scopus 로고
    • Incidence of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome
    • Miller DP, Kaye JA, Shea K, et al. Incidence of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome. Epidemiology. 2004;15(2):208-215.
    • (2004) Epidemiology , vol.15 , Issue.2 , pp. 208-215
    • Miller, D.P.1    Kaye, J.A.2    Shea, K.3
  • 31
    • 85014957424 scopus 로고    scopus 로고
    • Accessed August 2016
    • Toxicologist's review, BLA#99-1488, recombinant human interferon-α2b. http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/ucm094485.pdf. Accessed August 2016.
    • Toxicologist's Review, BLA#99-1488, Recombinant Human Interferon-α2b
  • 32
    • 85014878986 scopus 로고    scopus 로고
    • Accessed August 2016
    • Toxicologist's review, PLA#98-0261, recombinant human interferon-β1a. http://www.fda.gov/downloads/drugs/developmentapprovalprocess/howdrugsaredevelopedandapproved/approvalapplications/therapeuticbiologicapplications/ucm106138.pdf. Accessed August 2016.
    • Toxicologist's Review, PLA#98-0261, Recombinant Human Interferon-β1a
  • 33
    • 0345601517 scopus 로고    scopus 로고
    • Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis
    • Ebers GC; PRISMS (Prevention of Relapses and Disability by Interferon β-1a Subcutaneously in Multiple Sclerosis) Study Group. Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis. Lancet. 1998;352(9139):1498-1504.
    • (1998) Lancet , vol.352 , Issue.9139 , pp. 1498-1504
    • Ebers, G.C.1
  • 34
    • 22744434433 scopus 로고    scopus 로고
    • Causation and causal inference in epidemiology
    • Rothman KJ, Greenland S. Causation and causal inference in epidemiology. Am J Public Health. 2005;95(suppl 1):S144-S150.
    • (2005) Am J Public Health , vol.95 , pp. S144-S150
    • Rothman, K.J.1    Greenland, S.2
  • 35
    • 84896546294 scopus 로고    scopus 로고
    • Thrombotic microangiopathy in interferon beta treated multiple sclerosis patients: Review of literature and report of two new cases
    • Vosoughi R, Marriott JJ. Thrombotic microangiopathy in interferon beta treated multiple sclerosis patients: review of literature and report of two new cases. Mult Scler Relat Disord. 2014;3(3):321-325.
    • (2014) Mult Scler Relat Disord , vol.3 , Issue.3 , pp. 321-325
    • Vosoughi, R.1    Marriott, J.J.2
  • 36
    • 84898544834 scopus 로고    scopus 로고
    • Malignant hypertension and interferon-beta: A case report
    • Rubin S, Lacraz A, Galantine V, Gosse P. Malignant hypertension and interferon-beta: a case report. J Hum Hypertens. 2014;28(5):340-341.
    • (2014) J Hum Hypertens , vol.28 , Issue.5 , pp. 340-341
    • Rubin, S.1    Lacraz, A.2    Galantine, V.3    Gosse, P.4
  • 37
    • 0037451167 scopus 로고    scopus 로고
    • Interferon and granulopoiesis signatures in systemic lupus erythematosus blood
    • Bennett L, Palucka AK, Arce E, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med. 2003;197(6):711-723.
    • (2003) J Exp Med. , vol.197 , Issue.6 , pp. 711-723
    • Bennett, L.1    Palucka, A.K.2    Arce, E.3
  • 38
    • 57649133143 scopus 로고    scopus 로고
    • Cutaneous histopathological findings of Aicardi-Goutières syndrome, overlap with chilblain lupus
    • Kolivras A, Aeby A, Crow YJ, Rice GI, Sass U, André J. Cutaneous histopathological findings of Aicardi-Goutières syndrome, overlap with chilblain lupus. J Cutan Pathol. 2008;35(8):774-778.
    • (2008) J Cutan Pathol. , vol.35 , Issue.8 , pp. 774-778
    • Kolivras, A.1    Aeby, A.2    Crow, Y.J.3    Rice, G.I.4    Sass, U.5    André, J.6
  • 39
    • 18444387671 scopus 로고    scopus 로고
    • Cerebral thrombotic microangiopathy and antiphospholipid antibodies in Aicardi-Goutieres syndrome - report of two sisters
    • Rasmussen M, Skullerud K, Bakke SJ, Lebon P, Jahnsen FL. Cerebral thrombotic microangiopathy and antiphospholipid antibodies in Aicardi-Goutieres syndrome - report of two sisters. Neuropediatrics. 2005;36(1):40-44.
    • (2005) Neuropediatrics , vol.36 , Issue.1 , pp. 40-44
    • Rasmussen, M.1    Skullerud, K.2    Bakke, S.J.3    Lebon, P.4    Jahnsen, F.L.5
  • 40
    • 84872140900 scopus 로고    scopus 로고
    • The spectrum of renal thrombotic microangiopathy in lupus nephritis
    • Song D, Wu LH, Wang FM, et al. The spectrum of renal thrombotic microangiopathy in lupus nephritis. Arthritis Res Ther. 2013;15:R12.
    • (2013) Arthritis Res Ther. , vol.15 , pp. R12
    • Song, D.1    Wu, L.H.2    Wang, F.M.3
  • 41
    • 0036281509 scopus 로고    scopus 로고
    • The neuropathology and pathogenesis of systemic lupus erythematosus
    • Scolding NJ, Joseph FG. The neuropathology and pathogenesis of systemic lupus erythematosus. Neuropathol Appl Neurobiol. 2002;28(3):173-189.
    • (2002) Neuropathol Appl Neurobiol , vol.28 , Issue.3 , pp. 173-189
    • Scolding, N.J.1    Joseph, F.G.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.